Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 979515, 9 pages
Review Article

Gut Microbiota: Association with NAFLD and Metabolic Disturbances

Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar São João, Institute for Research and Innovation in Health Sciences, Faculty of Medicine, University of Porto, Alameda Professor Hernâni Monteiro, 4200-319 Porto, Portugal

Received 3 November 2014; Accepted 7 January 2015

Academic Editor: Maria Carmen Collado

Copyright © 2015 E. Lau et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [19 citations]

The following is the list of published articles that have cited the current article.

  • Yiqing Chu, Yanping Wan, Renying Xu, Xiaomin Zhang, Yiquan Zhou, Zhiqi Chen, and Liping Lu, “Relationship between serum ferritin and nonalcoholic fatty liver diseases in obese children,” Chinese Journal of Clinical Nutrition, vol. 23, no. 5, pp. 266–270, 2015. View at Publisher · View at Google Scholar
  • Zhi-Jun Duan, and Zhen-Ling Zhang, “Gut-liver axis: An important target for prevention and treatment of liver diseases,” World Chinese Journal of Digestology, vol. 24, no. 23, pp. 3454–3460, 2016. View at Publisher · View at Google Scholar
  • Morris, Wankhade, Shankar, Britton, Koch, Matthew R. Panasevich, Chintapalli, Thyfault, and Rector, “Gut microbiota are linked to increased susceptibility to hepatic steatosis in low-aerobic-capacity rats fed an acute high-fat diet,” American Journal of Physiology - Gastrointestinal and Liver Physiology, vol. 311, no. 1, pp. G166–G179, 2016. View at Publisher · View at Google Scholar
  • Shigeatsu Hashimoto, “Glucose Metabolism and Liver,” The Liver in Systemic Diseases, pp. 77–103, 2016. View at Publisher · View at Google Scholar
  • Niki Katsiki, Dimitri P. Mikhailidis, and Christos S. Mantzoros, “Non-alcoholic fatty liver disease and dyslipidemia: an update,” Metabolism, 2016. View at Publisher · View at Google Scholar
  • Asmaa A. Althani, Hany E. Marei, Wedad S. Hamdi, Gheyath K. Nasrallah, Mohamed E. El Zowalaty, Souhaila Al Khodor, Maha Al-Asmakh, Hassan Abdel-Aziz, and Carlo Cenciarelli, “Human Microbiome and its Association With Health and Diseases,” Journal of Cellular Physiology, vol. 231, no. 8, pp. 1688–1694, 2016. View at Publisher · View at Google Scholar
  • Kazunori Adachi, Akihiro Shimozato, Naotaka Ogasawara, Yasushi Funaki, Chiho Goto, Yoshiharu Yamaguchi, Kunio Kasugai, Tomoya Sugiyama, Masahide Ebi, and Makoto Sasaki, “Association of Intestinal Microbiota with Metabolic Markers and Dietary Habits in Patients with Type 2 Diabetes,” Digestion, vol. 94, no. 2, pp. 66–72, 2016. View at Publisher · View at Google Scholar
  • Floriana Elvira Ionică, Simona Negreș, Ludovic Bejenaru, Cornelia Bejenaru, and Cornel Chiriță, “Pharmacological Approaches for Nonalcoholic Fatty Liver Disease,” Romanian Journal of Diabetes Nutrition and Metabolic Diseases, vol. 23, no. 3, 2016. View at Publisher · View at Google Scholar
  • Xue-Feng Yang, and Jian He, “Gut microbiota and nonalcoholic fatty liver disease,” World Chinese Journal of Digestology, vol. 25, no. 27, pp. 2480–2485, 2017. View at Publisher · View at Google Scholar
  • Yusuf Yilmaz, and Fatih Eren, “Nonalcoholic steatohepatitis and gut microbiota: Future perspectives on probiotics in metabolic liver diseases,” Turkish Journal of Gastroenterology, vol. 28, no. 5, pp. 327–328, 2017. View at Publisher · View at Google Scholar
  • Siavash Mansouri, Mostafa Qorbani, Milad Daneshi-Maskooni, Seyed Ali Jazayeri-Tehrani, Seyed Mahdi Rezayat, Seyed Moayed Alavian, and Mohammad-Javad Hosseinzadeh-Attar, “Efficacy of nanocurcumin supplementation on insulin resistance, lipids, inflammatory factors and nesfatin among obese patients with non-alcoholic fatty liver disease (NAFLD): A trial protocol,” BMJ Open, vol. 7, no. 7, 2017. View at Publisher · View at Google Scholar
  • Milad Daneshi-Maskooni, Seyed Ali Keshavarz, Siavash Mansouri, Mostafa Qorbani, Seyed Moayed Alavian, Mahtab Badri-Fariman, Seyed Ali Jazayeri-Tehrani, and Gity Sotoudeh, “The effects of green cardamom on blood glucose indices, lipids, inflammatory factors, paraxonase-1, sirtuin-1, and irisin in patients with nonalcoholic fatty liver disease and obesity: study protocol for a randomized controlled trial,” Trials, vol. 18, no. 1, 2017. View at Publisher · View at Google Scholar
  • Aafke W. F. Janssen, Tom Houben, Saeed Katiraei, Wieneke Dijk, Lily Boutens, Nieke van der Bolt, Zeneng Wang, J. Mark Brown, Stanley L. Hazen, St?phane Mandard, Ronit Shiri-Sverdlov, Folkert Kuipers, Ko Willems van Dijk, Jacques Vervoort, Rinke Stienstra, Guido J. E. J. Hooiveld, and Sander Kersten, “Modulation of the gut microbiota impacts nonalcoholic fatty liver disease: a potential role for bile acids,” Journal of Lipid Research, vol. 58, no. 7, pp. 1399–1416, 2017. View at Publisher · View at Google Scholar
  • Yan Geng, Ning Gao, Yaofeng Jin, Li Xue, Jiru Xu, Juntao He, Xiaolan Lu, Ming Li, Xiaokang Wu, Zeshi Liu, and Jiali Liu, “Probiotics may delay the progression of nonalcoholic fatty liver disease by restoring the gut microbiota structure and improving intestinal endotoxemia,” Scientific Reports, vol. 7, 2017. View at Publisher · View at Google Scholar
  • Junli Ma, Qihang Zhou, and Houkai Li, “Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanisms and Therapy,” Nutrients, vol. 9, no. 10, pp. 1124, 2017. View at Publisher · View at Google Scholar
  • David Porras, Esther Nistal, Susana Martínez-Flórez, Sandra Pisonero-Vaquero, José Luis Olcoz, Ramiro Jover, Javier González-Gallego, María Victoria García-Mediavilla, and Sonia Sánchez-Campos, “Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation,” Free Radical Biology and Medicine, vol. 102, pp. 188–202, 2017. View at Publisher · View at Google Scholar
  • Michael Fricker, Bridie J. Goggins, Sean Mateer, Bernadette Jones, Richard Y. Kim, Shaan L. Gellatly, Andrew G. Jarnicki, Nicholas Powell, Brian G. Oliver, Graham Radford-Smith, Nicholas J. Talley, Marjorie M. Walker, Simon Keely, and Philip M. Hansbro, “Chronic cigarette smoke exposure induces systemic hypoxia that drives intestinal dysfunction,” JCI Insight, vol. 3, no. 3, 2018. View at Publisher · View at Google Scholar
  • Renger G. Tiessen, Ciara A. Kennedy, Bradley T. Keller, Nancy Levin, Lisette Acevedo, Bronislava Gedulin, Andre A. van Vliet, Alejandro Dorenbaum, and Melissa Palmer, “Safety, tolerability and pharmacodynamics of apical sodium-dependent bile acid transporter inhibition with volixibat in healthy adults and patients with type 2 diabetes mellitus: a randomised placebo-controlled trial,” BMC Gastroenterology, vol. 18, no. 1, 2018. View at Publisher · View at Google Scholar
  • Emma T. Saltzman, Talia Palacios, Michael Thomsen, and Luis Vitetta, “Intestinal Microbiome Shifts, Dysbiosis, Inflammation, and Non-alcoholic Fatty Liver Disease,” Frontiers in Microbiology, vol. 9, 2018. View at Publisher · View at Google Scholar